Intergenic

Intergenic Limited

Net liabilitiesStaff down 23%ActiveLatest figures: 2025Abridged accountsCompany only7 years on the register

Private limited company registered in London, classed under “Other retail sale in non-specialised stores”.

Headline figures

FY to Dec 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

Pro

Every figure for all 5 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

From the filed balance sheets · £

Balance sheet	2022	2023	2024	2025
Fixed assets
Current assets
of which debtors
of which cash
Creditors due within a year
Net current assets
Creditors due after a year
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Cash ratioCash for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

8 balance-sheet lines and 3 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

›What does Intergenic do?

Private limited company registered in London, classed under “Other retail sale in non-specialised stores”.

›How much turnover does Intergenic make?

Answered in the full report

›Is Intergenic profitable?

Intergenic's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Intergenic?

Answered in the full report

›Where is Intergenic based?

Its registered office is Quadrant House, Floor 6, 4 Thomas More Square, London, E1W 1YW, in London.

›When was Intergenic founded?

Intergenic Limited was incorporated on 10 October 2019.

›Is Intergenic still trading?

The register lists Intergenic Limited as active.